Item 2. Properties
Item 2. Properties
Properties for our core operations include our corporate office and headquarters located in Stamford, Connecticut, our primary operating laboratory located in Gaithersburg, Maryland, and a satellite meeting space located in New York City; each are leased spaces with an aggregate of approximately 115,000 square feet. The lease agreements for these properties expire in 2034, 2031, and 2026, respectively.
As previously disclosed, we exited our reproductive health and somatic tumor testing business in 2022. We are actively marketing for sublet our two laboratories in Connecticut as well as a portion of our headquarters in Stamford, Connecticut. The lease agreements for these properties expire in 2030 and 2036, respectively.
We believe that our current facilities are suitable and adequate to meet our current needs. See Note 9, “ Leases ” to our consolidated financial statements for more information on our future lease obligations.
53
Table of Co ntents
Item 3. Legal Proceedings
Information regarding legal proceedings can be found in the consolidated financial statements in Note 10, “ Purchase Commitments and Contingencies ” included in this Annual Report.
Item 4. Mine Safety Disclosures
None.
54
Table of Co ntents
Part II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.